BiomX Inc. (AMEX: PHGE) stock jumped 18.75% on Tuesday to $0.38 against a previous-day closing price of $0.32. With 0.7 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.42 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.4000 whereas the lowest price it dropped to was $0.3220. The 52-week range on PHGE shows that it touched its highest point at $2.14 and its lowest point at $0.13 during that stretch. It currently has a 1-year price target of $5.25. Beta for the stock currently stands at 1.08.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PHGE was up-trending over the past week, with a rise of 33.80%, but this was up by 95.07% over a month. Three-month performance surged to 0.72% while six-month performance fell -50.98%. The stock lost -73.61% in the past year, while it has gained 103.54% so far this year.
Float and Shares Shorts:
At present, 29.91 million PHGE shares are outstanding with a float of 24.17 million shares on hand for trading. On Oct 13, 2022, short shares totaled 0.25 million, which was 0.84% higher than short shares on Sep 14, 2022. In addition to Mr. Jonathan Eitan Solomon MBA as the firm’s CEO & Director, Mr. Assaf Oron serves as its Chief Bus. Officer.
Through their ownership of 20.67% of PHGE’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 30.78% of PHGE, in contrast to 3.31% held by mutual funds. Shares owned by individuals account for 0.74%. As the largest shareholder in PHGE with 2.28% of the stake, MM Asset Management, Inc. holds 684,451 shares worth 684,451. A second-largest stockholder of PHGE, Royce & Associates LP, holds 158,655 shares, controlling over 0.53% of the firm’s shares. Millennium Management LLC is the third largest shareholder in PHGE, holding 87,757 shares or 0.29% stake. With a 0.53% stake in PHGE, the Royce Smaller Companies Growth Fu is the largest stakeholder. A total of 158,655 shares are owned by the mutual fund manager. The Bridgeway Ultra Small Company Mar, which owns about 0.20% of PHGE stock, is the second-largest Mutual Fund holder. It holds 58,700 shares valued at 10977.0. Psagot ETF holds 0.01% of the stake in PHGE, owning 3,081 shares worth 576.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for PHGE since 4 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With PHGE analysts setting a high price target of $10.00 and a low target of $2.00, the average target price over the next 12 months is $5.25. Based on these targets, PHGE could surge 2531.58% to reach the target high and rise by 426.32% to reach the target low. Reaching the average price target will result in a growth of 1281.58% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. PHGE will report FY 2022 earnings on 02/28/2024. Analysts have provided yearly estimates in a range of -$0.93 being high and -$1.01 being low. For PHGE, this leads to a yearly average estimate of -$0.98. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. BiomX Inc. surprised analysts by -$0.01 when it reported -$0.23 EPS against a consensus estimate of -$0.22. The surprise factor in the prior quarter was $0.02. Based on analyst estimates, the high estimate for the next quarter is -$0.20 and the low estimate is -$0.25. The average estimate for the next quarter is thus -$0.23.
Summary of Insider Activity:
Insiders traded PHGE stock several times over the past three months with 0 Buys and 9 Sells. In these transactions, 0 shares were bought while 29,120 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has risen to 62 over the past year. The total number of shares bought during that period was 0 while 640,821 shares were sold.